Radioimmunotherapy (RIT) requires reliable new radioisotopes supply chains. Our options assessment identified new avenues for radioisotope-sourcing, the competitive positioning options and partnership proposals towards business development.
Nuclear-21 performed the assessment using our IsoSup market analysis and simulation tool in order to analyse the market prospects and appropriate pricing options declining into investment and market development strategies.
